MBL77 Options
Not all people with CLL call for therapy. Even with all new advances, the iwCLL however endorses watchful observation for clients with asymptomatic ailment.86 This advice relies on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Equally trials